{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:12:49Z","timestamp":1791403969857,"version":"4.3.3"},"reference-count":132,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012579","name":"Iowa Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.bioorg.2020.104326","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T18:39:42Z","timestamp":1601404782000},"page":"104326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["A perspective on potential target proteins of COVID-19: Comparison with SARS-CoV for designing new small molecules"],"prefix":"10.1016","volume":"104","author":[{"given":"Devendra","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourav","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupinder","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjinder Singh","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2020.104326_b0005","series-title":"Features, Evaluation and Treatment Coronavirus (COVID-19)","author":"Cascella","year":"2020"},{"key":"10.1016\/j.bioorg.2020.104326_b0010","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/CMR.00102-14","article-title":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease","volume":"28","author":"Chan","year":"2015","journal-title":"Clin. Microb. Rev."},{"key":"10.1016\/j.bioorg.2020.104326_b0015","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jmii.2020.02.001","article-title":"Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV","volume":"53","author":"Lee","year":"2020","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.bioorg.2020.104326_b0020","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nrmicro3143","article-title":"A decade after SARS: strategies for controlling emerging coronaviruses","volume":"11","author":"Graham","year":"2013","journal-title":"Nat. Rev. Microb."},{"key":"10.1016\/j.bioorg.2020.104326_b0025","first-page":"869","article-title":"Severe acute respiratory syndrome: historical, epidemiologic, and clinical features","volume":"33","author":"Hui","year":"2019","journal-title":"Infect. Dis. Clin."},{"key":"10.1016\/j.bioorg.2020.104326_b0030","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1128\/JVI.02041-07","article-title":"Mechanisms of zoonotic severe acute respiratory syndrome coronavirus host range expansion in human airway epithelium","volume":"82","author":"Sheahan","year":"2008","journal-title":"J. Virol."},{"issue":"2020","key":"10.1016\/j.bioorg.2020.104326_b0035","first-page":"507","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2019","journal-title":"The Lancet"},{"key":"10.1016\/j.bioorg.2020.104326_b0040","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(20)30260-9","article-title":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study","volume":"395","author":"Wu","year":"2020","journal-title":"The Lancet"},{"key":"10.1016\/j.bioorg.2020.104326_b0045","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"Mokhtari","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2020.104326_b0050","article-title":"Outbreak of a novel coronavirus","volume":"18","author":"Du Toit","year":"2020","journal-title":"Nat. Rev. Microb."},{"key":"10.1016\/j.bioorg.2020.104326_b0055","doi-asserted-by":"crossref","first-page":"e13209","DOI":"10.1111\/eci.13209","article-title":"The novel Chinese coronavirus (2019-nCoV) infections: challenges for fighting the storm","volume":"50","author":"Bassetti","year":"2020","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.bioorg.2020.104326_b0060","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.bioorg.2020.104326_b0065","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S1473-3099(20)30068-2","article-title":"Pandemic potential of 2019-nCoV","volume":"20","author":"Thompson","year":"2020","journal-title":"Lancet. Infect. Dis."},{"key":"10.1016\/j.bioorg.2020.104326_b0070","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1001\/jama.2020.2565","article-title":"Presumed asymptomatic carrier transmission of COVID-19","volume":"323","author":"Bai","year":"2020","journal-title":"JAMA"},{"issue":"2020","key":"10.1016\/j.bioorg.2020.104326_b0075","first-page":"1708","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2019","journal-title":"New Eng. J. Med."},{"key":"10.1016\/j.bioorg.2020.104326_b0080","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1473-3099(20)30086-4","article-title":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study","volume":"20","author":"Shi","year":"2020","journal-title":"Lancet. Infect. Dis"},{"key":"10.1016\/j.bioorg.2020.104326_b0085","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.meegid.2018.04.031","article-title":"Newly emerged porcine enteric alphacoronavirus in southern China: identification, origin and evolutionary history analysis","volume":"62","author":"Fu","year":"2018","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.bioorg.2020.104326_b0090","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.antiviral.2013.10.013","article-title":"Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS","volume":"101","author":"Drexler","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bioorg.2020.104326_b0095","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40248-017-0101-8","article-title":"The history and epidemiology of Middle East respiratory syndrome corona virus","volume":"12","author":"Al-Osail","year":"2017","journal-title":"Multidiscip. Respir. Med."},{"key":"10.1016\/j.bioorg.2020.104326_b0100","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12985-015-0422-1","article-title":"Bat origin of human coronaviruses","volume":"12","author":"Hu","year":"2015","journal-title":"Virol. J."},{"key":"10.1016\/j.bioorg.2020.104326_b0105","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nature12711","article-title":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor","volume":"503","author":"Ge","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2020.104326_b0110","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1073\/pnas.1517719113","article-title":"SARS-like WIV1-CoV poised for human emergence","volume":"113","author":"Menachery","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2020.104326_b0115","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1128\/JVI.02582-15","article-title":"Isolation and characterization of a novel bat coronavirus closely related to the direct progenitor of severe acute respiratory syndrome coronavirus","volume":"90","author":"Yang","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2020.104326_b0120","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.1128\/JVI.03079-15","article-title":"Bat severe acute respiratory syndrome-like coronavirus WIV1 encodes an extra accessory protein, ORFX, involved in modulation of the host immune response","volume":"90","author":"Zeng","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2020.104326_b0125","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1126\/science.aac8608","article-title":"Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia","volume":"351","author":"Sabir","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2020.104326_b0130","doi-asserted-by":"crossref","first-page":"e00373","DOI":"10.1128\/mBio.00373-17","article-title":"Further evidence for bats as the evolutionary source of Middle East respiratory syndrome coronavirus","volume":"8","author":"Anthony","year":"2017","journal-title":"MBio"},{"key":"10.1016\/j.bioorg.2020.104326_b0135","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.coviro.2016.01.004","article-title":"Cross host transmission in the emergence of MERS coronavirus","volume":"16","author":"Reusken","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.bioorg.2020.104326_b0140","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV)\u2014update","volume":"14","author":"Organization","year":"2014","journal-title":"Disease Outbreak News"},{"key":"10.1016\/j.bioorg.2020.104326_b0145","doi-asserted-by":"crossref","first-page":"11858","DOI":"10.1128\/JVI.01755-15","article-title":"Evidence for an ancestral association of human coronavirus 229E with bats","volume":"89","author":"Corman","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2020.104326_b0150","doi-asserted-by":"crossref","first-page":"9864","DOI":"10.1073\/pnas.1604472113","article-title":"Link of a ubiquitous human coronavirus to dromedary camels","volume":"113","author":"Corman","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2020.104326_b0155","doi-asserted-by":"crossref","first-page":"e01953","DOI":"10.1128\/JVI.01953-16","article-title":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history","volume":"91","author":"Tao","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2020.104326_b0160","doi-asserted-by":"crossref","first-page":"vex012","DOI":"10.1093\/ve\/vex012","article-title":"Global patterns in coronavirus diversity","volume":"3","author":"Anthony","year":"2017","journal-title":"Virus Evol."},{"key":"10.1016\/j.bioorg.2020.104326_b0165","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1128\/JVI.06540-11","volume":"86","author":"Woo","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2020.104326_b0170","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1128\/JVI.02605-06","article-title":"Evolutionary Insights into the Ecology of","volume":"81","author":"Chen","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2020.104326_b0175","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3201\/eid1310.070448","article-title":"Evolutionary relationships between bat coronaviruses and their hosts","volume":"13","author":"Cui","year":"2007","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.bioorg.2020.104326_b0180","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1099\/vir.0.054841-0","article-title":"Highly diversified coronaviruses in neotropical bats","volume":"94","author":"Corman","year":"2013","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bioorg.2020.104326_b0185","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s10393-016-1116-x","article-title":"Coronavirus infection and diversity in bats in the Australasian region","volume":"13","author":"Smith","year":"2016","journal-title":"EcoHealth"},{"key":"10.1016\/j.bioorg.2020.104326_b0190","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.1128\/JVI.00697-06","article-title":"Prevalence and genetic diversity of coronaviruses in bats from China","volume":"80","author":"Tang","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2020.104326_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2017.03.019","article-title":"Extensive diversity of coronaviruses in bats from China","volume":"507","author":"Lin","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.bioorg.2020.104326_b0200","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2020.104326_b0205","article-title":"Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir","author":"Yin","year":"2020","journal-title":"Science Accepted"},{"key":"10.1016\/j.bioorg.2020.104326_b0210","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of M pro from SARS-CoV-2 and discovery of its inhibitors","author":"Jin","year":"2020","journal-title":"Nature Accepted"},{"key":"10.1016\/j.bioorg.2020.104326_b0215","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.abb7269","article-title":"A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV","volume":"368","author":"Yuan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2020.104326_b0220","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2020.104326_b0225","doi-asserted-by":"crossref","first-page":"105951","DOI":"10.1016\/j.ijantimicag.2020.105951","article-title":"Coronavirus disease 2019 (COVID-19): current status and future perspectives","volume":"55","author":"Li","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.bioorg.2020.104326_b0230","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1080\/22221751.2020.1745095","article-title":"Laboratory diagnosis of emerging human coronavirus infections\u2014the state of the art","volume":"9","author":"Loeffelholz","year":"2020","journal-title":"Emerg. Microbes. Infect."},{"key":"10.1016\/j.bioorg.2020.104326_b0235","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.bioorg.2020.104326_b0240","unstructured":"G. Eysenbach, Infodemiology: tracking flu-related searches on the web for syndromic surveillance, in: AMIA Annual Symposium Proceedings, American Medical Informatics Association, 2006, pp. 244."},{"key":"10.1016\/j.bioorg.2020.104326_b0245","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1099\/jmm.0.05320-0","article-title":"Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China","volume":"52","author":"Zhao","year":"2003","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.bioorg.2020.104326_b0250","unstructured":"W.H. Organization, Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003, 2003. http:\/\/www.who.int\/csr\/sars\/country\/table2004_04_21\/en\/index. html."},{"key":"10.1016\/j.bioorg.2020.104326_b0255","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0140-6736(03)13077-2","article-title":"Coronavirus as a possible cause of severe acute respiratory syndrome","volume":"361","author":"Peiris","year":"2003","journal-title":"Lancet"},{"issue":"2003","key":"10.1016\/j.bioorg.2020.104326_b0260","article-title":"Update: outbreak of severe acute respiratory syndrome-worldwide","volume":"52","author":"Tsang","year":"2003","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.bioorg.2020.104326_b0265","unstructured":"W. Update, 31-Coronavirus never before seen in humans is the cause of SARS, Unprecedented Collaboration Identifies New Pathogen in Record Time 16, 2003. https:\/\/www.who.int\/csr\/sars\/archive\/2003_2004_2016\/en\/."},{"key":"10.1016\/j.bioorg.2020.104326_b0270","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.antiviral.2013.09.028","article-title":"Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research","volume":"100","author":"Simmons","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bioorg.2020.104326_b0275","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1073\/pnas.0809524106","article-title":"Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites","volume":"106","author":"Belouzard","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2020.104326_b0280","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.0306446101","article-title":"Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry","volume":"101","author":"Simmons","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2020.104326_b0285","doi-asserted-by":"crossref","first-page":"e1007236","DOI":"10.1371\/journal.ppat.1007236","article-title":"Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2","volume":"14","author":"Song","year":"2018","journal-title":"PLoS Pathogen"},{"key":"10.1016\/j.bioorg.2020.104326_b0290","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor","volume":"309","author":"Li","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2020.104326_b0295","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.virusres.2014.11.021","article-title":"Host cell proteases: critical determinants of coronavirus tropism and pathogenesis","volume":"202","author":"Millet","year":"2015","journal-title":"Virus Res."},{"key":"10.1016\/j.bioorg.2020.104326_b0300","doi-asserted-by":"crossref","first-page":"11876","DOI":"10.1073\/pnas.0505577102","article-title":"Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry","volume":"102","author":"Simmons","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2020.104326_b0305","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2020.104326_b0310","doi-asserted-by":"crossref","first-page":"8017","DOI":"10.1128\/JVI.00998-13","article-title":"Novel inhibitors of severe acute respiratory syndrome coronavirus entry that act by three distinct mechanisms","volume":"87","author":"Adedeji","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2020.104326_b0315","doi-asserted-by":"crossref","first-page":"15829","DOI":"10.1074\/jbc.M600697200","article-title":"Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody","volume":"281","author":"Prabakaran","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2020.104326_b0320","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1093\/emboj\/cdf327","article-title":"Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra \u03b1-helical domain","volume":"21","author":"Anand","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.bioorg.2020.104326_b0325","doi-asserted-by":"crossref","first-page":"13190","DOI":"10.1073\/pnas.1835675100","article-title":"The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor","volume":"100","author":"Yang","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2020.104326_b0330","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1128\/JVI.02114-07","article-title":"Structures of two coronavirus main proteases: implications for substrate binding and antiviral drug design","volume":"82","author":"Xue","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2020.104326_b0335","doi-asserted-by":"crossref","first-page":"22677","DOI":"10.1038\/srep22677","article-title":"Structure of main protease from human coronavirus NL63: insights for wide spectrum anti-coronavirus drug design","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2020.104326_b0340","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1371\/journal.pbio.0030324","article-title":"Design of wide-spectrum inhibitors targeting coronavirus main proteases","volume":"3","author":"Yang","year":"2005","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bioorg.2020.104326_b0345","doi-asserted-by":"crossref","unstructured":"J. Ziebuhr, The coronavirus replicase, in: Coronavirus Replication and Reverse Genetics, Springer, 2005, pp. 57\u201394.","DOI":"10.1007\/3-540-26765-4_3"},{"key":"10.1016\/j.bioorg.2020.104326_b0350","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1007\/s00705-012-1404-x","article-title":"Biochemical characterization of a recombinant SARS coronavirus nsp12 RNA-dependent RNA polymerase capable of copying viral RNA templates","volume":"157","author":"Ahn","year":"2012","journal-title":"Arch. Virol."},{"key":"10.1016\/j.bioorg.2020.104326_b0355","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/nar\/gkp904","article-title":"The RNA polymerase activity of SARS-coronavirus nsp12 is primer dependent","volume":"38","author":"Te Velthuis","year":"2010","journal-title":"Nucleic Acid Res."},{"key":"10.1016\/j.bioorg.2020.104326_b0360","doi-asserted-by":"crossref","first-page":"E3900","DOI":"10.1073\/pnas.1323705111","article-title":"One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities","volume":"111","author":"Subissi","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2020.104326_b0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-10280-3","article-title":"Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors","volume":"10","author":"Kirchdoerfer","year":"2019","journal-title":"Nat. Comm."},{"key":"10.1016\/j.bioorg.2020.104326_b0370","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nsmb999","article-title":"Insights into SARS-CoV transcription and replication from the structure of the nsp7\u2013nsp8 hexadecamer","volume":"12","author":"Zhai","year":"2005","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bioorg.2020.104326_b0375","doi-asserted-by":"crossref","first-page":"12905","DOI":"10.1128\/JVI.79.20.12905-12913.2005","article-title":"Structural genomics of the severe acute respiratory syndrome coronavirus: nuclear magnetic resonance structure of the protein nsP7","volume":"79","author":"Peti","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2020.104326_b0380","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jmb.2010.07.043","article-title":"NMR structure of the SARS-CoV nonstructural protein 7 in solution at pH 6.5","volume":"402","author":"Johnson","year":"2010","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bioorg.2020.104326_b0385","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1126\/science.abb7498","article-title":"Structure of the RNA-dependent RNA polymerase from COVID-19 virus","volume":"368","author":"Gao","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2020.104326_b0390","doi-asserted-by":"crossref","first-page":"8416","DOI":"10.1093\/nar\/gkv838","article-title":"Discovery of an essential nucleotidylating activity associated with a newly delineated conserved domain in the RNA polymerase-containing protein of all nidoviruses","volume":"43","author":"Lehmann","year":"2015","journal-title":"Nucleic Acid Res."},{"key":"10.1016\/j.bioorg.2020.104326_b0395","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/wrna.1164","article-title":"RNA synthetic mechanisms employed by diverse families of RNA viruses","volume":"4","author":"McDonald","year":"2013","journal-title":"Wiley Interdiscip Rev. RNA"},{"key":"10.1016\/j.bioorg.2020.104326_b0400","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ejmech.2017.08.071","article-title":"Structural insights of cyclin dependent kinases: implications in design of selective inhibitors","volume":"142","author":"Kalra","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104326_b0405","doi-asserted-by":"crossref","first-page":"7760","DOI":"10.1021\/acsnano.0c04006","article-title":"Nanotechnology for COVID-19: therapeutics and vaccine research","volume":"14","author":"Chauhan","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioorg.2020.104326_b0410","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3390\/v12040428","article-title":"Molecular mechanism of evolution and human infection with sars-cov-2","volume":"12","author":"He","year":"2020","journal-title":"Virus"},{"key":"10.1016\/j.bioorg.2020.104326_b0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2019.1621213","article-title":"Computational investigation of potential inhibitors of novel coronavirus 2019 through structure-based virtual screening, molecular dynamics and density functional theory studies","volume":"2020","author":"Mishra","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2020.104326_b0420","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2020.104326_b0425","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.3390\/molecules25102271","article-title":"Virtual screening of natural products against Type II transmembrane serine protease (TMPRSS2), the priming agent of coronavirus 2 (SARS-CoV-2)","volume":"25","author":"Rahman","year":"2020","journal-title":"Molecule"},{"key":"10.1016\/j.bioorg.2020.104326_b0430","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.1073\/pnas.2002589117","article-title":"Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells","volume":"117","author":"Matsuyama","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2020.104326_b0435","doi-asserted-by":"crossref","first-page":"e105114","DOI":"10.15252\/embj.20105114","article-title":"SARS-CoV-2 receptor ACE 2 and TMPRSS 2 are primarily expressed in bronchial transient secretory cells","volume":"39","author":"Lukassen","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.bioorg.2020.104326_b0440","doi-asserted-by":"crossref","first-page":"e01815","DOI":"10.1128\/JVI.01815-18","article-title":"TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection","volume":"93","author":"Iwata-Yoshikawa","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2020.104326_b0445","first-page":"2020030360","article-title":"Transcriptional inhibition of host viral entry proteins as a therapeutic strategy for SARS-CoV-2","author":"Wang","year":"2020","journal-title":"Preprints"},{"key":"10.1016\/j.bioorg.2020.104326_b0450","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.antiviral.2015.01.011","article-title":"Protease inhibitors targeting coronavirus and filovirus entry","volume":"116","author":"Zhou","year":"2015","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bioorg.2020.104326_b0455","doi-asserted-by":"crossref","first-page":"103417","DOI":"10.1016\/j.bioorg.2019.103417","article-title":"A novel cathepsin L inhibitor prevents the progression of idiopathic pulmonary fibrosis","volume":"94","author":"Yuan","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.104326_b0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2020.104326_b0465","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.molcel.2020.04.022","article-title":"A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells","volume":"78","author":"Hoffmann","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bioorg.2020.104326_b0470","doi-asserted-by":"crossref","first-page":"104742","DOI":"10.1016\/j.antiviral.2020.104742","article-title":"The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade","volume":"176","author":"Coutard","year":"2020","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bioorg.2020.104326_b0475","article-title":"Virus strain of a mild COVID-19 patient in Hangzhou representing a new trend in SARS-CoV-2 evolution related to Furin cleavage site","author":"Xi","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.bioorg.2020.104326_b0480","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1172\/JCI89857","article-title":"Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects","volume":"127","author":"Bekerman","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bioorg.2020.104326_b0485","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/v12010045","article-title":"The serine\/threonine kinase AP2-associated kinase 1 plays an important role in rabies virus entry","volume":"12","author":"Wang","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.bioorg.2020.104326_b0490","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","article-title":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease","volume":"395","author":"Richardson","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2020.104326_b0495","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S1473-3099(20)30132-8","article-title":"COVID-19: combining antiviral and anti-inflammatory treatments","volume":"20","author":"Stebbing","year":"2020","journal-title":"Lancet. Infect. Dis"},{"key":"10.1016\/j.bioorg.2020.104326_b0500","doi-asserted-by":"crossref","first-page":"105967","DOI":"10.1016\/j.ijantimicag.2020.105967","article-title":"Janus kinase inhibitor baricitinib is not an ideal option for management of COVID-19","volume":"55","author":"Praveen","year":"2020","journal-title":"Int. J. Antimicrob."},{"key":"10.1016\/j.bioorg.2020.104326_b0505","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nature25146","article-title":"Dynamics of phosphoinositide conversion in clathrin-mediated endocytic traffic","volume":"552","author":"He","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2020.104326_b0510","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1600-0854.2009.00915.x","article-title":"PIKfyve regulation of endosome-linked pathways","volume":"10","author":"de Lartigue","year":"2009","journal-title":"Traffic"},{"key":"10.1016\/j.bioorg.2020.104326_b0515","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.bbrc.2009.03.063","article-title":"YM201636, an inhibitor of retroviral budding and PIKfyve-catalyzed PtdIns (3, 5) P2 synthesis, halts glucose entry by insulin in adipocytes","volume":"382","author":"Ikonomov","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2020.104326_b0520","doi-asserted-by":"crossref","first-page":"e35069","DOI":"10.1371\/journal.pone.0035069","article-title":"Apilimod inhibits the production of IL-12 and IL-23 and reduces dendritic cell infiltration in psoriasis","volume":"7","author":"Wada","year":"2012","journal-title":"PLoS ONE"},{"issue":"2020","key":"10.1016\/j.bioorg.2020.104326_b0525","first-page":"1","article-title":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak\u2013an update on the status","volume":"7","author":"Guo","year":"2019","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.bioorg.2020.104326_b0530","doi-asserted-by":"crossref","first-page":"58","DOI":"10.18433\/jpps31002","article-title":"Current drugs with potential for treatment of COVID-19: a literature review","volume":"23","author":"Rabby","year":"2020","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"2020","key":"10.1016\/j.bioorg.2020.104326_b0535","first-page":"149","article-title":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)","volume":"19","author":"Li","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2020","key":"10.1016\/j.bioorg.2020.104326_b0540","first-page":"58","article-title":"Discovering drugs to treat coronavirus disease 2019 COVID-19","volume":"14","author":"Dong","year":"2019","journal-title":"Drug Discov. Ther."},{"key":"10.1016\/j.bioorg.2020.104326_b0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.tips.2020.03.006","article-title":"Ongoing clinical trials for the management of the COVID-19 pandemic","author":"Lythgoe","year":"2020","journal-title":"Trends Pharmacol. Sci. Accepted"},{"key":"10.1016\/j.bioorg.2020.104326_b0550","article-title":"Outcome reporting from protocols of clinical trials of Coronavirus Disease 2019 (COVID-19): a review","author":"Qiu","year":"2020","journal-title":"MedRxiv Accepted"},{"key":"10.1016\/j.bioorg.2020.104326_b0555","article-title":"Systematic review of the registered clinical trials of coronavirus diseases 2019 (COVID-19)","author":"Zhu","year":"2020","journal-title":"MedRxiv Accepted"},{"key":"10.1016\/j.bioorg.2020.104326_b0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41421-019-0132-8","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discov."},{"key":"10.1016\/j.bioorg.2020.104326_b0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","author":"Gautret","year":"2020","journal-title":"Int. J. Antimicrob. Agent Accepted"},{"key":"10.1016\/j.bioorg.2020.104326_b0570","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir\u2013ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"New Eng. J. Med."},{"key":"10.1016\/j.bioorg.2020.104326_b0575","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.3346\/jkms.2020.35.e79","article-title":"Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: the application of lopinavir\/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR","volume":"35","author":"Lim","year":"2020","journal-title":"J. Korean Med. Sci."},{"issue":"2020","key":"10.1016\/j.bioorg.2020.104326_b0580","first-page":"929","article-title":"First case of 2019 novel coronavirus in the United States","volume":"382","author":"Holshue","year":"2019","journal-title":"New Eng. J. Med."},{"key":"10.1016\/j.bioorg.2020.104326_b0585","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe Covid-19","author":"Grein","year":"2020","journal-title":"New Eng. J. Med. Accepted"},{"key":"10.1016\/j.bioorg.2020.104326_b0590","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1073\/pnas.1922083117","article-title":"Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection","volume":"117","author":"de Wit","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2020.104326_b0595","doi-asserted-by":"crossref","first-page":"101615","DOI":"10.1016\/j.tmaid.2020.101615","article-title":"Remdesivir as a possible therapeutic option for the COVID-19","volume":"34","author":"Al-Tawfiq","year":"2020","journal-title":"Travel Med. Infect. Dis."},{"key":"10.1016\/j.bioorg.2020.104326_b0600","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal3653","article-title":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","volume":"9","author":"Sheahan","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bioorg.2020.104326_b0605","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.bioorg.2020.104326_b0610","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","article-title":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor","volume":"100","author":"Furuta","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bioorg.2020.104326_b0615","article-title":"Experimental treatment with favipiravir for COVID-19: an open-label control study","author":"Cai","year":"2020","journal-title":"Engineering Accepted"},{"key":"10.1016\/j.bioorg.2020.104326_b0620","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nrd3652","article-title":"Ruxolitinib","volume":"11","author":"Mesa","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2020.104326_b0625","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2165\/00003088-200544080-00003","article-title":"Clinical pharmacokinetics of losartan","volume":"44","author":"Sica","year":"2005","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.bioorg.2020.104326_b0630","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2165\/11209910-000000000-00000","article-title":"Dapagliflozin","volume":"72","author":"Plosker","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.bioorg.2020.104326_b0635","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2165\/00003495-200969050-00007","article-title":"Tocilizumab","volume":"69","author":"Oldfield","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.bioorg.2020.104326_b0640","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25801","article-title":"Tocilizumab treatment in COVID-19: a single center experience","author":"Luo","year":"2020","journal-title":"J. Med. Virol. Accepted"},{"key":"10.1016\/j.bioorg.2020.104326_b0645","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1182\/bloodadvances.2020001907","article-title":"First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab","volume":"4","author":"Zhang","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.bioorg.2020.104326_b0650","series-title":"Transplantation Proceedings","first-page":"S7","article-title":"Sirolimus: its discovery, biological properties, and mechanism of action","author":"Sehgal","year":"2003"},{"key":"10.1016\/j.bioorg.2020.104326_b0655","doi-asserted-by":"crossref","first-page":"100028","DOI":"10.1016\/j.medidd.2020.100028","article-title":"Can early and high intravenous dose of vitamin C prevent and treat coronavirus disease 2019 (COVID-19)?","volume":"5","author":"Cheng","year":"2020","journal-title":"Med. Drug Discov."},{"key":"10.1016\/j.bioorg.2020.104326_b0660","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3390\/nu12040988","article-title":"Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths","volume":"12","author":"Grant","year":"2020","journal-title":"Nutrients"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820316242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820316242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T15:43:18Z","timestamp":1763566998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206820316242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":132,"alternative-id":["S0045206820316242"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.104326","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A perspective on potential target proteins of COVID-19: Comparison with SARS-CoV for designing new small molecules","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.104326","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104326"}}